Biology Reference
In-Depth Information
[99] Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS, et al. Synovial
membrane cytokine expression is predictive of joint damage progression in rheu-
matoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis
Rheum 2006;54:1122-31.
[100] Yagi Y, Andoh A, Inatomi O, Tsujikawa T, Fujiyama Y. Inflammatory responses
induced by interleukin-17 family members in human colonic subepithelial myofibro-
blasts. J Gastroenterol 2007;42:746-53.
[101] Ratajczak P, Janin A, Peffault de Latour R, Leboeuf C, Desveaux A, Keyvanfar K, et al.
Th17/Treg ratio in human graft-versus-host disease. Blood 2010;116:1165-71.
[102] Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, et al. Mucosal FOXP3+
regulatory T cells are numerically deficient in acute and chronic GvHD. Blood
2006;107:1717-23.
[103] Broady R, Yu J, Chow V, Tantiworawit A, Kang C, Berg K, et al. Cutaneous GVHD is
associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood
2010;116:5748-51.
[104] Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, et al. Interleukin-
17-producing T-helper cells as new potential player mediating graft-versus-host
disease in patients undergoing allogeneic stem-cell transplantation. Transplantation
2009;88:1261-72.
[105] Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E. Genetic polymorphisms
predicting the outcome of bone marrow transplants. Br J Haematol 2004;127:479-90.
[106] Middleton PG, Taylor PRA, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene poly-
morphisms associating with severe acute graft-versus-host disease in HLA-identical
sibling transplants. Blood 1998;92:3943-8.
[107] Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient
tumour necrosis factor-alpha and interleukin-10 gene polymorphisms associate with
early mortality and acute graft-versus-host disease severity in HLA matched sibling
bone marrow transplants. Blood 1999;94:3941-6.
[108] Socié G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, et al. Both genetic and
clinical factors predict the development of graft-versus-host disease after allogeneic
hematopoietic stem cell transplantation. Transplantation 2001;72:699-705.
[109] Nordang GB, Viken MK, Hollis-Moffatt JE, Merriman TR, Førre ØT Helgetveit K,
Kvien TK, et al. Association analysis of the interleukin 17A gene in Caucasian
rheumatoid arthritis patients from Norway and New Zealand. Rheumatology (Oxf )
2009;48:367-70.
[110] Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. The
influence of polymorphisms of interleukin-17A and interleukin-17F genes on the sus-
ceptibility to ulcerative colitis. J Clin Immunol 2008;28:44-9.
[111] Espinoza JL, Takami A, Onizuka M, Kawase T, Sao H, Akiyama H, et al. Japan Marrow
Donor Program. A single nucleotide polymorphism of IL-17 gene in the recipient is
associated with acute GVHD after HLA-matched unrelated BMT. Bone Marrow Trans-
plant 2011;46:1455-63.
[112] Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, Akiyama H, et al. Japan Marrow
Donor Program. A genetic variant in the IL-17 promoter is functionally associated with
acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One
2011;6:e26229.
[113] Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide
association study identifies IL23R as an inflammatory bowel disease gene. Science
2006;314:1461-3.
[114] Elmaagacli AH, Koldehoff M, Landt O, Beelen DW. Relation of an interleukin-23
receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell
transplantation. Bone Marrow Transplant 2008;41:821-6.
[115] Gruhn B, Intek J, Pfaffendorf N, Zell R, Corbacioglu S, Zintl F, et al. Polymorphism of
interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-
host disease after hematopoietic stem cell transplantation in children. Biol Blood
Marrow Transplant 2009;15:1571-7.
[116] Wermke M, Maiwald S, Schmelz R, Thiede C, Schetelig J, Ehninger G, et al. Genetic
variations of interleukin-23R (1143A>G) and BPI (A654G), but not of NOD2, are associ-
ated with acute graft versus host disease after allogeneic transplantation. Biol Blood
Marrow Transplant 2010;16:1718-27.
[117] Nguyen Y, Al-Lehibi A, Gorbe E, Li E, Haagenson M, Wang T, et al. Insufficient evidence
for association of NOD2/CARD15 or other inflammatory bowel disease-associated
markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor
transplantation. Blood 2010;115:3625-31.
[118] Sploski R, Leonard WJ. The yin and yang of interleukin 21 in allergy, autoimmunity and
cancer. Curr Opin Immunol 2008;20:295-301.
296
Search WWH ::
Custom Search